Annual Cash & Cash Equivalents
$482.05 M
-$263.32 M-35.33%
September 27, 2024
Summary
- As of February 7, 2025, DLB annual cash & cash equivalents is $482.05 million, with the most recent change of -$263.32 million (-35.33%) on September 27, 2024.
- During the last 3 years, DLB annual cash & cash equivalents has fallen by -$743.33 million (-60.66%).
- DLB annual cash & cash equivalents is now -60.66% below its all-time high of $1.23 billion, reached on September 24, 2021.
Performance
DLB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$520.82 M
+$38.77 M+8.04%
December 1, 2024
Summary
- As of February 7, 2025, DLB quarterly cash and cash equivalents is $520.82 million, with the most recent change of +$38.77 million (+8.04%) on December 1, 2024.
- Over the past year, DLB quarterly cash and cash equivalents has dropped by -$188.71 million (-26.60%).
- DLB quarterly cash and cash equivalents is now -57.50% below its all-time high of $1.23 billion, reached on September 24, 2021.
Performance
DLB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DLB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.3% | -26.6% |
| 3 y3 years | -60.7% | -50.7% |
| 5 y5 years | -39.5% | -28.2% |
DLB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.7% | at low | -50.7% | +8.0% |
| 5 y | 5-year | -60.7% | at low | -57.5% | +8.0% |
| alltime | all time | -60.7% | +2032.8% | -57.5% | +741.1% |
Dolby Laboratories Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $520.82 M(+8.0%) |
| Sep 2024 | $482.05 M(-35.3%) | $482.05 M(-35.0%) |
| Jun 2024 | - | $741.64 M(+4.5%) |
| Mar 2024 | - | $709.53 M(+8.0%) |
| Dec 2023 | - | $656.82 M(-11.9%) |
| Sep 2023 | $745.36 M(+20.2%) | $745.36 M(-2.6%) |
| Jun 2023 | - | $765.08 M(+11.1%) |
| Mar 2023 | - | $688.44 M(+9.9%) |
| Dec 2022 | - | $626.16 M(+1.0%) |
| Sep 2022 | $620.13 M(-49.4%) | $620.13 M(-27.8%) |
| Jun 2022 | - | $858.90 M(-4.6%) |
| Mar 2022 | - | $900.39 M(-14.8%) |
| Dec 2021 | - | $1.06 B(-13.8%) |
| Sep 2021 | $1.23 B(+14.3%) | $1.23 B(+0.5%) |
| Jun 2021 | - | $1.22 B(+10.4%) |
| Mar 2021 | - | $1.10 B(-0.5%) |
| Dec 2020 | - | $1.11 B(+3.6%) |
| Sep 2020 | $1.07 B(+34.5%) | $1.07 B(+25.4%) |
| Jun 2020 | - | $855.10 M(+18.0%) |
| Mar 2020 | - | $724.93 M(-2.2%) |
| Dec 2019 | - | $741.43 M(-7.0%) |
| Sep 2019 | $797.21 M(-13.2%) | $797.21 M(+11.3%) |
| Jun 2019 | - | $716.56 M(-1.4%) |
| Mar 2019 | - | $726.60 M(-8.1%) |
| Dec 2018 | - | $790.79 M(-13.9%) |
| Sep 2018 | $918.06 M(+46.4%) | $918.06 M(+10.7%) |
| Jun 2018 | - | $829.62 M(+17.6%) |
| Mar 2018 | - | $705.52 M(+18.3%) |
| Dec 2017 | - | $596.39 M(-4.9%) |
| Sep 2017 | $627.02 M(+21.5%) | $627.02 M(+5.8%) |
| Jun 2017 | - | $592.62 M(+11.3%) |
| Mar 2017 | - | $532.51 M(+3.8%) |
| Dec 2016 | - | $512.84 M(-0.6%) |
| Sep 2016 | $516.11 M(-3.0%) | $516.11 M(-14.0%) |
| Jun 2016 | - | $599.99 M(+15.1%) |
| Mar 2016 | - | $521.20 M(+11.6%) |
| Dec 2015 | - | $467.10 M(-12.2%) |
| Sep 2015 | $531.93 M(-6.4%) | $531.93 M(+13.0%) |
| Jun 2015 | - | $470.87 M(-8.4%) |
| Mar 2015 | - | $513.99 M(+25.6%) |
| Dec 2014 | - | $409.12 M(-28.0%) |
| Sep 2014 | $568.47 M | $568.47 M(-3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $590.10 M(+3.7%) |
| Mar 2014 | - | $568.90 M(+17.4%) |
| Dec 2013 | - | $484.64 M(+6.7%) |
| Sep 2013 | $454.40 M(-7.8%) | $454.40 M(+11.2%) |
| Jun 2013 | - | $408.56 M(+24.4%) |
| Mar 2013 | - | $328.51 M(+3.9%) |
| Dec 2012 | - | $316.19 M(-35.8%) |
| Sep 2012 | $492.60 M(-10.7%) | $492.60 M(-26.5%) |
| Jun 2012 | - | $670.41 M(-10.4%) |
| Mar 2012 | - | $747.99 M(+14.3%) |
| Dec 2011 | - | $654.41 M(+18.7%) |
| Sep 2011 | $551.51 M(+1.0%) | $551.51 M(-7.2%) |
| Jun 2011 | - | $594.60 M(+14.3%) |
| Mar 2011 | - | $520.27 M(+20.0%) |
| Dec 2010 | - | $433.64 M(-20.6%) |
| Sep 2010 | $545.86 M(+20.9%) | $545.86 M(+5.2%) |
| Jun 2010 | - | $519.10 M(+24.4%) |
| Mar 2010 | - | $417.35 M(+2.7%) |
| Dec 2009 | - | $406.24 M(-10.1%) |
| Sep 2009 | $451.68 M(+14.4%) | $451.68 M(+24.3%) |
| Jun 2009 | - | $363.38 M(-2.5%) |
| Mar 2009 | - | $372.53 M(-7.4%) |
| Dec 2008 | - | $402.43 M(+1.9%) |
| Sep 2008 | $394.76 M(+7.1%) | $394.76 M(+6.7%) |
| Jun 2008 | - | $369.91 M(+6.4%) |
| Mar 2008 | - | $347.50 M(+24.0%) |
| Dec 2007 | - | $280.25 M(-23.9%) |
| Sep 2007 | $368.47 M(-10.7%) | $368.47 M(+13.1%) |
| Jun 2007 | - | $325.91 M(-3.4%) |
| Mar 2007 | - | $337.40 M(-17.6%) |
| Dec 2006 | - | $409.26 M(-0.8%) |
| Sep 2006 | $412.49 M(+10.8%) | $412.49 M(+10.5%) |
| Jun 2006 | - | $373.42 M(-17.1%) |
| Mar 2006 | - | $450.58 M(+11.4%) |
| Dec 2005 | - | $404.50 M(+8.6%) |
| Sep 2005 | $372.40 M(+373.1%) | $372.40 M(+3.0%) |
| Jun 2005 | - | $361.55 M(+3.1%) |
| Mar 2005 | - | $350.65 M(+272.7%) |
| Dec 2004 | - | $94.09 M(+19.5%) |
| Sep 2004 | $78.71 M(+27.1%) | $78.71 M(+27.1%) |
| Sep 2003 | $61.92 M(+174.0%) | $61.92 M |
| Sep 2001 | $22.60 M | - |
FAQ
- What is Dolby Laboratories annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Dolby Laboratories?
- What is Dolby Laboratories annual cash & cash equivalents year-on-year change?
- What is Dolby Laboratories quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Dolby Laboratories?
- What is Dolby Laboratories quarterly cash and cash equivalents year-on-year change?
What is Dolby Laboratories annual cash & cash equivalents?
The current annual cash & cash equivalents of DLB is $482.05 M
What is the all time high annual cash & cash equivalents for Dolby Laboratories?
Dolby Laboratories all-time high annual cash & cash equivalents is $1.23 B
What is Dolby Laboratories annual cash & cash equivalents year-on-year change?
Over the past year, DLB annual cash & cash equivalents has changed by -$263.32 M (-35.33%)
What is Dolby Laboratories quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DLB is $520.82 M
What is the all time high quarterly cash and cash equivalents for Dolby Laboratories?
Dolby Laboratories all-time high quarterly cash and cash equivalents is $1.23 B
What is Dolby Laboratories quarterly cash and cash equivalents year-on-year change?
Over the past year, DLB quarterly cash and cash equivalents has changed by -$188.71 M (-26.60%)